ArticlePloS one2013

The conformational control inhibitor of tyrosine kinases DCC-2036 is effective for imatinib-resistant cells expressing T674I FIP1L1-PDGFRα.

Yingying Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.